Amandine Grimm

Dr. Amandine Grimm

University of Basel, Switzerland
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2017 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
Amandine GrimmAmandine Grimm
Amandine Grimm
Anne EckertAnne Eckert
Anne Eckert
Aging is defined as a progressive time‐related accumulation of changes responsible for or at least involved in the increased susceptibility to disease and death. The brain seems to be particularly sensitive to the aging process since the appearance of neurodegenerative diseases, including Alzheimer's disease, is exponential with the increasing age. Mitochondria were placed at the center of the ‘free‐radical theory of aging’, because these paramount organelles are not only the main producers of energy in the cells, but also to main source of reactive oxygen species. Thus, in this review, we aim to look at brain aging processes from a mitochondrial point of view by asking: (i) What happens to brain mitochondrial bioenergetics and dynamics during aging? (ii) Why is the brain so sensitive to the age‐related mitochondrial impairments? (iii) Is there a sex difference in the age‐induced mitochondrial dysfunction? Understanding mitochondrial physiology in the context of brain aging may help identify therapeutic targets against neurodegeneration.This article is part of a series “Beyond Amyloid”. image

1 March 2018 in Cell Metabolism
Verified
Journal Article
Closed access
KSKaren Schmitt
Karen Schmitt
Amandine GrimmAmandine Grimm
Amandine Grimm
RDRobert Dallmann
Robert Dallmann
BOBjoern Oettinghaus
Bjoern Oettinghaus
LRLisa Michelle Restelli
Lisa Michelle Restelli
Anne EckertAnne Eckert
Anne Eckert

14 October 2015 in Biogerontology
Verified
Journal Article
Closed access
PDF file
Amandine GrimmAmandine Grimm
Amandine Grimm
KFKristina Friedland
Kristina Friedland
Anne EckertAnne Eckert
Anne Eckert

27 April 2018 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
ILImane Lejri
Imane Lejri
Amandine GrimmAmandine Grimm
Amandine Grimm
Anne EckertAnne Eckert
Anne Eckert
Mitochondria play an essential role in the generation of steroid hormones including the female sex hormones. These hormones are, in turn, able to modulate mitochondrial activities. Mitochondria possess crucial roles in cell maintenance, survival and well-being, because they are the main source of energy as well as of reactive oxygen species (ROS) within the cell. The impairment of these important organelles is one of the central features of aging. In women’s health, estrogen plays an important role during adulthood not only in the estrous cycle, but also in the brain via neuroprotective, neurotrophic and antioxidant modes of action. The hypestrogenic state in the peri- as well as in the prolonged postmenopause might increase the vulnerability of elderly women to brain degeneration and age-related pathologies. However, the underlying mechanisms that affect these processes are not well elucidated. Understanding the relationship between estrogen and mitochondria might therefore provide better insights into the female aging process. Thus, in this review, we first describe mitochondrial dysfunction in the aging brain. Second, we discuss the estrogen-dependent actions on the mitochondrial activity, including recent evidence of the estrogen—brain-derived neurotrophic factor and estrogen—sirtuin 3 (SIRT3) pathways, as well as their potential implications during female aging.

15 June 2012 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
KSKaren Schmitt
Karen Schmitt
Amandine GrimmAmandine Grimm
Amandine Grimm
AKAnna Kazmierczak
Anna Kazmierczak
JSJoanna B. Strosznajder
Joanna B. Strosznajder
JGJürgen Götz
Jürgen Götz
Anne EckertAnne Eckert
Anne Eckert
Significance: Alzheimer's disease (AD) is an age-related progressive neurodegenerative disorder mainly affecting elderly individuals. The pathology of AD is characterized by amyloid plaques (aggregates of amyloid-β [Aβ]) and neurofibrillary tangles (aggregates of tau), but the mechanisms underlying this dysfunction are still partially unclear. Recent Advances: A growing body of evidence supports mitochondrial dysfunction as a prominent and early, chronic oxidative stress-associated event that contributes to synaptic abnormalities and, ultimately, selective neuronal degeneration in AD. Critical Issues: In this review, we discuss on the one hand whether mitochondrial decline observed in brain aging is a determinant event in the onset of AD and on the other hand the close interrelationship of this organelle with Aβ and tau in the pathogenic process underlying AD. Moreover, we summarize evidence from aging and Alzheimer models showing that the harmful trio “aging, Aβ, and tau protein” triggers mitochondrial dysfunction through a number of pathways, such as impairment of oxidative phosphorylation (OXPHOS), elevation of reactive oxygen species production, and interaction with mitochondrial proteins, contributing to the development and progression of the disease. Future Directions: The aging process may weaken the mitochondrial OXPHOS system in a more general way over many years providing a basis for the specific and destructive effects of Aβ and tau. Establishing strategies involving efforts to protect cells at the mitochondrial level by stabilizing or restoring mitochondrial function and energy homeostasis appears to be challenging, but very promising route on the horizon. Antioxid. Redox Signal. 16, 1456–1466.

1 August 2014 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
AEAnne Eckert
Anne Eckert
RNRebecca Maree Nisbet
Rebecca Maree Nisbet
Amandine GrimmAmandine Grimm
Amandine Grimm
JGJürgen Götz
Jürgen Götz